The invention concerns a cellprotective, neuroprotective and retinoprotective medicine, whereof the active principale is selected among a group of compounds consisting of Ramipril or ramiprilat combined with folic acid. Said medicine is used for prevention, or even for improving visual acuity and visual field in normal subjects, as well as for treating ophtalmologic pathologies in particular : glaucoma, diabetic retionpathy , age related macular degeneration, heredintary dystrophy of the retina, uveitis, ammetropia (myopia, presbyopia). Said medicine could be used in general conditions for treating general pathlogies.
